Zobrazeno 1 - 10
of 29
pro vyhledávání: '"John M. A. Northover"'
Publikováno v:
Colorectal Disease. 18:811-814
Aim A questionnaire completed by members of the ACPGBI in 1997 was a precursor to the PROSPER trial. It showed a significant variation in favoured practice for the surgical treatment of external rectal prolapse. We repeated the same questionnaire to
Autor:
Helen Meadows, Rob Glynne-Jones, Roger D James, S Wan, David Sebag-Montefiore, John M. A. Northover, Mark Jitlal, Jonathan A. Ledermann
Publikováno v:
British Journal of Cancer
Background: The first UKCCCR Anal Cancer Trial (1996) demonstrated the benefit of chemoradiation over radiotherapy (RT) alone for treating epidermoid anal cancer, and it became the standard treatment. Patients in this trial have now been followed up
Autor:
Alastair Windsor, Jeremy I Livingstone, Mark Harrison, Richard Ashford, Suzannah Mawdsley, Andreas Makris, Peter MacDonald, John M. A. Northover, Richard A. Harrison, Richard Novell, John Meyrick-Thomas, Marina Wallace, Paul Richman, Melanie Osborne, Rob Glynne-Jones, Juliet Grainger, Ian C. Mitchell
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 63:745-752
Purpose: This study set out to determine the impact of a positive circumferential resection margin (CRM) (R1-R2) and pathologic downstaging on local recurrence and survival in patients with borderline resectable or unresectable rectal adenocarcinoma
Autor:
Rob Glynne-Jones, Robin K. S. Phillips, Matthew T. Harrison, Richard Ashford, Roger A Harrison, A. Windsor, I.C. Mitchell, J. Meyrick Thomas, P.J. Mcdonald, Andreas Makris, J. Grainger, Marina Wallace, Paul Richman, J.R. Novell, John M. A. Northover, R. Hughes, Jeremy I Livingstone
Publikováno v:
International Journal of Colorectal Disease. 21:11-17
Local excision is considered inappropriate treatment for T3–T4 rectal adenocarcinomas, as it cannot provide prognostic information regarding lymph node involvement and has a high risk of pelvic recurrence. Preoperative chemoradiation (CRT) studies
Autor:
Bruce George, J. Wheeler, Nicola S Fearnhead, Andrew Cook, Laura Magill, Azmina Verjee, I. Geh, John M. A. Northover, J. Tiernan
Publikováno v:
Colorectal Disease
AIM:The modified Delphi approach is an established method for reaching a consensus opinion among a group of experts in a particular field. We have used this technique to survey the entire membership of the Association of Coloproctology of Great Brita
Autor:
Roger B. Buchanan, Ian S. Fentiman, Chris Baughan, John M. A. Northover, Margot Gosney, Stephen L. George, Peter Simmonds, C.E. Davis, Chris Williams, L Best
Publikováno v:
The Lancet. 356:968-974
Summary Background The effectiveness of surgery for colorectal cancer depends on it being carried out safely, which allows most patients to return to productive lives, with an improved postoperative life expectancy, or at least one that is not dimini
Publikováno v:
Diseases of the Colon & Rectum. 39:1039-1043
PURPOSE: This study was designed to evaluate the operative treatments performed on patients with perianal Crohn's disease at a tertiary referral colorectal university hospital and to determine the efficacy of management by assessing patient satisfact
Autor:
Alec McDonald, Mark Jitlal, John M. A. Northover, David Sebag-Montefiore, Simon Gollins, Rob Glynne-Jones, Roger D James, Helen Meadows, Richard Adams
Publikováno v:
International journal of radiation oncology, biology, physics. 81(5)
Purpose: The United Kingdom Coordinating Committee on Cancer Research anal cancer trial demonstrated the benefit of combined modality treatment (CMT) using radiotherapy (RT), infusional 5-fluorouracil, and mitomycin C over RT alone. The present study
Autor:
Wendy S, Atkin, Rob, Edwards, Ines, Kralj-Hans, Kate, Wooldrage, Andrew R, Hart, John M A, Northover, D Max, Parkin, Jane, Wardle, Stephen W, Duffy, Jack, Cuzick, S, Fitzpatrick
Publikováno v:
Lancet (London, England). 375(9726)
Summary Background Colorectal cancer is the third most common cancer worldwide and has a high mortality rate. We tested the hypothesis that only one flexible sigmoidoscopy screening between 55 and 64 years of age can substantially reduce colorectal c
Publikováno v:
Postgraduate medical journal. 86(1012)
Objectives Comorbid conditions in colorectal cancer patients can influence both clinical eligibility for treatment and survival. We aimed to evaluate the effect of comorbidity on 1 year survival from colorectal cancer, and to assess whether this effe